Device Trial Radar · NCT03267134
Hydrus Microstent for Refractory Open-Angle Glaucoma
Last checked: Nov 19, 2026Latest source record: Jan 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
217
Actual
Start
Aug 1, 2017
Primary completion
Dec 16, 2022
Study completion Dec 16, 2022
Sponsor
- Lead sponsor
- Ivantis, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 30, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent in patients with refractory open-angle glaucoma.
Conditions
- Open-angle Glaucoma
Interventions
Hydrus MicrostentDevice
Device implanted into the Schlemm's canal of the eye to provide a natural outflow pathway for aqueous humor, leading to a reduction in intraocular pressure (IOP). The Hydrus Microstent is intended for lifetime use of the glaucoma patient.
Ophthalmic surgeryProcedure
Implantation of the Hydrus Microstent performed under either local or topical ophthalmic anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Greater Than or Equal to a 20 Percent Decrease From Baseline in Mean Diurnal Intraocular Pressure (MDIOP) at Month 12 While Maintaining the Same or Fewer Number of Medications as at BaselineTime frame: Baseline, Month 12
Locations
20 sites in 5 countries. Site status is shown where the registry gives one.
Vold Vision
Fayetteville, Arkansas
Sacramento Eye Consultants
Sacramento, California
Eye Center of Northern Colorado
Fort Collins, Colorado
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.